Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"RADICAL" FDA REFORM MEASURE WILL NOT PASS CONGRESS THIS YEAR, KENNEDY STAFFER WARNS; SENATE FAVORS BIPARTISAN APPROACH, IMPROVING CURRENT SYSTEM

This article was originally published in The Gray Sheet

Executive Summary

FDA reform efforts should focus on improving management within the agency and reducing regulatory burdens on manufacturers to speed product approvals, David Nexon, minority staff director for health for the Senate Labor and Human Resources Committee, said at a Feb. 7 conference in Washington, D.C. hosted by the Progress & Freedom Foundation.

You may also be interested in...



Device Reform Legislation Via PDUFA Still A Possibility; Other Vehicles Await

The House Energy & Commerce Committee appears determined to push device reforms through Congress this year, even if Prescription Drug User Fee Act reauthorization does not provide a suitable vehicle

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel